ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia.

Alak Manna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.